Company / Revenue per Share
ARDELYX, INC. Revenue per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$1.67
FY2025
5-year range
$0.11 / $1.67
FY2021-FY2025
Trend
+18.9%
vs FY2024
Sector context
#96 of 154
Health Care
What the data says
At $1.67, ARDELYX, INC.'s revenue per share ranks #96 of 154 in the Health Care sector. Revenue per Share has increased for 7 consecutive years, from $0.00 in FY2018 to $1.67 in FY2025.
Based on SEC 10-K filings.
1.67 in FY2025 with a 5-year CAGR of +81.2%.
Improved from $0.54 to $1.67 over the past 2 years.
Health Care sector context is included.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- +60.8%
- 5-Year CAGR
- +81.2%
- 10-Year CAGR
- -
Sector benchmark
#96 of 154 in Health CareTop 62% of 154This company $1.67 Sector average $15.09
▼
-89.0% below sector average
Key checks
Key Insights
- ARDELYX, INC.'s revenue per share has grown for 7 consecutive years.
- In FY2025, revenue per share increased 18.9% year-over-year.
- Ranks #96 out of 154 companies in the Health Care sector.
- Lowest revenue per share in the period was in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.41 (distress zone, below 1.8 threshold)
- Negative profit margin: -11.7%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.67 | +18.9% |
| FY2024 | $1.40 | +161.8% |
| FY2023 | $0.54 | +33.6% |
| FY2022 | $0.40 | +271.4% |
| FY2021 | $0.11 | +26.6% |
| FY2020 | $0.09 | +0.9% |
| FY2019 | $0.08 | +13284.8% |
| FY2018 | $0.00 | -99.9% |
| FY2017 | $0.51 | -58.3% |
| FY2016 | $1.22 | -5.8% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026